Bausch Health Companies Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Bausch Health Companies Inc 公司

Bausch Health Companies Inc. 是一家全球多元化製藥公司。該公司通過 Bausch + Lomb Corporation 開發、製造和營銷主要在胃腸病學 (GI)、肝病學、神經病學和皮膚病學等治療領域的產品。其 Salix 部門在美國銷售 GI 產品。其國際部門在美國和波多黎各以外銷售品牌藥品、品牌仿製藥和其他產品（Bausch + Lomb 產品和 Solta Medical 美容醫療設備的銷售除外）。其 Solta Medical 部門在全球銷售 Solta Medical 美容醫療設備。其多元化部門在美國銷售神經病學和某些其他治療類別的藥品。其 Bausch + Lomb 部門在全球銷售 Bausch + Lomb 視力保健、外科和醫藥產品。

Bausch Health Companies Inc簡介



公司代碼BHC

公司名稱Bausch Health Companies Inc

上市日期Sep 20, 1994

CEOMr. Thomas J. Appio

員工數量20700

證券類型Ordinary Share

年結日Sep 20

公司地址2150 St. Elzear Blvd. West

城市LAVAL

上市交易所The Toronto Stock Exchange

國家Canada

郵編H7L 4A8

電話18003611448

網址https://www.bauschhealth.com/

公司代碼BHC

上市日期Sep 20, 1994

CEOMr. Thomas J. Appio

Bausch Health Companies Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Thomas J. Appio

Chief Executive Officer, Director

627.22K

--

Mr. Jean-Jacques (JJ) Charhon

Executive Vice President, Chief Financial Officer

199.24K

--

Dr. Amy B. Wechsler, M.D.

Independent Director

107.66K

+1.00%

Ms. Aimee J. Lenar

Executive Vice President, US Pharma

25.38K

+212.92%

Mr. Robert N. Power

Independent Director

6.60K

-97.41%

Ms. Sandra Leung

Director

3.67K

--

Mr. Michael Goettler

Director

--

-100.00%

Mr. John A. Paulson ,

Independent Non-Executive Chairman of the Board

--

Dr. Richard C. Mulligan, Ph.D.

Independent Director

--

Ms. Sarah B. Kavanagh

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Thomas J. Appio

Chief Executive Officer, Director

627.22K

--

Mr. Jean-Jacques (JJ) Charhon

Executive Vice President, Chief Financial Officer

199.24K

--

Dr. Amy B. Wechsler, M.D.

Independent Director

107.66K

+1.00%

Ms. Aimee J. Lenar

Executive Vice President, US Pharma

25.38K

+212.92%

Mr. Robert N. Power

Independent Director

6.60K

-97.41%

Ms. Sandra Leung

Director

3.67K

--

收入明細

單位: USD更新時間: 10月6日週一

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Pharmaceutical Products

4.40B

45.67%

Device Products

2.24B

23.27%

OTC

1.90B

19.77%

Branded and Other Generic Products

979.00M

10.17%

Other Product Lines

107.00M

1.11%

地區USD

名稱

營收

佔比

United States and Puerto Rico

5.77B

59.92%

Other Foreign Countries

1.08B

11.25%

China (Country)

496.00M

5.15%

Canada

402.00M

4.18%

Poland

350.00M

3.64%

其他

1.53B

15.86%

業務

地區

業務USD

名稱

營收

佔比

Pharmaceutical Products

4.40B

45.67%

Device Products

2.24B

23.27%

OTC

1.90B

19.77%

Branded and Other Generic Products

979.00M

10.17%

Other Product Lines

107.00M

1.11%

股東統計

更新時間: 8月16日週六

持股股東

股東類型

持股股東

佔比

Paulson & Co. Inc.

19.10%

Meruelo (Alex)

9.92%

GoldenTree Asset Management, LP

9.25%

Nomura Securities Co., Ltd.

5.80%

Healthcare Of Ontario Pension Plan

3.51%

其他

52.43%

持股股東

佔比

Paulson & Co. Inc.

19.10%

Meruelo (Alex)

9.92%

GoldenTree Asset Management, LP

9.25%

Nomura Securities Co., Ltd.

5.80%

Healthcare Of Ontario Pension Plan

3.51%

其他

52.43%

股東類型

持股股東

佔比

Family Office

19.10%

Investment Advisor/Hedge Fund

15.00%

Individual Investor

10.86%

Research Firm

9.17%

Investment Advisor

7.88%

Hedge Fund

6.20%

Bank and Trust

4.48%

Pension Fund

4.24%

Private Equity

1.41%

其他

21.67%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

492

179.04M

48.32%

-88.35M

2025Q2

518

269.81M

72.96%

-35.70M

2025Q1

547

263.71M

71.37%

-49.89M

2024Q4

568

275.73M

74.96%

-32.06M

2024Q3

627

279.89M

77.25%

-44.78M

2024Q2

703

283.62M

78.54%

-59.67M

2024Q1

764

278.87M

76.11%

-93.72M

2023Q4

801

283.62M

78.55%

-85.16M

2023Q3

821

301.23M

82.72%

-52.06M

2023Q2

836

283.61M

80.53%

-76.52M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Paulson & Co. Inc.

70.76M

19.13%

+37.96M

+115.77%

Aug 14, 2025

Meruelo (Alex)

36.76M

9.94%

+148.73K

+0.41%

Mar 31, 2025

GoldenTree Asset Management, LP

34.25M

9.26%

+4.00M

+13.24%

Jun 30, 2025

Nomura Securities Co., Ltd.

21.50M

5.81%

-1.90M

-8.12%

Jun 30, 2025

Healthcare Of Ontario Pension Plan

13.00M

3.52%

--

Jun 30, 2025

The Vanguard Group, Inc.

11.70M

3.16%

+23.62K

+0.20%

Jun 30, 2025

Maple Rock Capital Partners, Inc.

7.81M

2.11%

+1.01M

+14.87%

Jun 30, 2025

National Bank of Canada

7.74M

2.09%

+229.78K

+3.06%

Jun 30, 2025

MFN Partners Management LP

6.00M

1.62%

--

Jun 30, 2025

Kohlberg Kravis Roberts & Co. L.P.

5.24M

1.42%

--

Jun 30, 2025

持股ETF



更新時間: 11月6日週四

機構名稱

佔比

Gotham 1000 Value ETF

0.16%

JPMorgan International Value ETF

0.14%

VanEck Pharmaceutical ETF

0.13%

FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF

0.11%

Schwab International Small-Cap Equity ETF

0.09%

iShares Intl Small Cap Equity Factor ETF

0.07%

DFA Dimensional International Small Cap ETF

0.06%

Schwab Fundamental International Equity ETF

0.04%

Invesco RAFI Developed Mkts ex-US ETF

0.03%

DFA Dimensional Intl Sustainability Core 1 ETF

0.01%

Gotham 1000 Value ETF

佔比0.16%

JPMorgan International Value ETF

佔比0.14%

VanEck Pharmaceutical ETF

佔比0.13%

FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF

佔比0.11%

Schwab International Small-Cap Equity ETF

佔比0.09%

iShares Intl Small Cap Equity Factor ETF

佔比0.07%

DFA Dimensional International Small Cap ETF

佔比0.06%

Schwab Fundamental International Equity ETF

佔比0.04%

Invesco RAFI Developed Mkts ex-US ETF

佔比0.03%

DFA Dimensional Intl Sustainability Core 1 ETF

佔比0.01%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據